Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolò Dasseni

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Recenti Progressi in Medicina|December 27, 2022
[Atherosclerosis and inflammation: no longer just theory, but a real perspective.]Nicolò Dasseni
Journal of Cardiac Failure|August 13, 2018
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With AccuracyMarco Metra, NicolÒ Dasseni, Carlo Lombardi
Cardiac Failure Review|March 9, 2019
The New Heart Failure Association Definition of Advanced Heart FailureMarco Metra, Elisabetta Dinatolo, Nicolò Dasseni
European Journal of Preventive Cardiology|May 9, 2019
Imaging subclinical atherosclerosis promises better cardiovascular primary preventionPompilio Faggiano, Nicolò Dasseni, Michael Henein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 18, 2018
Iron deficiency in heart failureElisabetta Dinatolo, Nicolò Dasseni, Marco Metra, et al.
ESC Heart Failure|December 21, 2018
Updates in heart failure: what last year brought to usElisabetta Dinatolo, Edoardo Sciatti, Markus S Anker, et al.
JACC. Heart Failure|March 14, 2021
Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future DirectionAndrew Y Lin, Elisabetta Dinatolo, Marco Metra, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 21, 2019
Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practicePompilio Faggiano, Francesco Fattirolli, Anna Frisinghelli, et al.
Plos One|February 12, 2026
Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AFCarmine Pizzi, Leopoldo Pagliani, Luca Dalle Carbonare, et al.
Giornale Italiano Di Cardiologia (2006)|November 8, 2019
[ANMCO statement: Arterial and venous thromboembolism: what implications for clinical practice?]Maurizio Giuseppe Abrignani, Iolanda Enea, Furio Colivicchi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|December 27, 2022
[Atherosclerosis and inflammation: no longer just theory, but a real perspective.]Nicolò Dasseni
Journal of Cardiac Failure|August 13, 2018
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With AccuracyMarco Metra, NicolÒ Dasseni, Carlo Lombardi
Cardiac Failure Review|March 9, 2019
The New Heart Failure Association Definition of Advanced Heart FailureMarco Metra, Elisabetta Dinatolo, Nicolò Dasseni
European Journal of Preventive Cardiology|May 9, 2019
Imaging subclinical atherosclerosis promises better cardiovascular primary preventionPompilio Faggiano, Nicolò Dasseni, Michael Henein
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 18, 2018
Iron deficiency in heart failureElisabetta Dinatolo, Nicolò Dasseni, Marco Metra, et al.
ESC Heart Failure|December 21, 2018
Updates in heart failure: what last year brought to usElisabetta Dinatolo, Edoardo Sciatti, Markus S Anker, et al.
JACC. Heart Failure|March 14, 2021
Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future DirectionAndrew Y Lin, Elisabetta Dinatolo, Marco Metra, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 21, 2019
Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practicePompilio Faggiano, Francesco Fattirolli, Anna Frisinghelli, et al.
Plos One|February 12, 2026
Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AFCarmine Pizzi, Leopoldo Pagliani, Luca Dalle Carbonare, et al.
Giornale Italiano Di Cardiologia (2006)|November 8, 2019
[ANMCO statement: Arterial and venous thromboembolism: what implications for clinical practice?]Maurizio Giuseppe Abrignani, Iolanda Enea, Furio Colivicchi, et al.
Pageof 2